ReShape Lifesciences Inc. expect revenue will continue to increase through the remainder of 2022 as focus on a targeted digital media campaign near bariatric surgical centers that sell the Lap-Band system.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2443 USD | -4.16% | +29.95% | -2.16% |
05-15 | ReShape Lifesciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-15 | Transcript : ReShape Lifesciences Inc., Q1 2024 Earnings Call, May 15, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.16% | 5.73M | |
+7.31% | 217B | |
+12.99% | 194B | |
+19.71% | 143B | |
+30.60% | 111B | |
+0.99% | 64.3B | |
+15.23% | 52.94B | |
+2.06% | 49.53B | |
-5.49% | 38.31B | |
-0.22% | 35.22B |
- Stock Market
- Equities
- RSLS Stock
- News ReShape Lifesciences Inc.
- ReShape Lifesciences Inc. Provides Revenue Guidance